The market taxonomy by type distinguishes four principal scanner architectures. Whole‑body systems, priced above $10 million, capture the full anatomical range and dominate the commercial segment, contributing approximately 45 % of total installations; their versatility underpins multi‑disciplinary usage across hospitals. Head‑only scanners, optimized for neuro‑imaging, are lighter and cost‑effective, representing about 30 % of deployments; their focused gradient design yields superior spatial resolution for brain studies, reinforcing the neurology share identified earlier. Hybrid PET‑MRI platforms, though still emerging, account for roughly 15 % of the market, driven by integrated metabolic and structural data that appeal to oncology and research programs. Finally, open‑bore or extremity‑focused units, comprising the remaining 10 %, address patient comfort and niche musculoskeletal applications, especially in pediatric and orthopedic settings. Each type’s pricing, footprint, and functional specialization directly influence capital‑expenditure cycles and after‑sales service revenue, thereby shaping the overall Ultra‑high Field MRI market size.